This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Flamma S.p.a.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Clelia Dallanoce: Inventor of Peptide Derivatives for Oxidative Stress
Introduction
Clelia Dallanoce is an inventor based in Milan, Italy, associated with Flamma S.p.a. Her work includes a patent concerning peptide derivatives designed to address the effects of lipid oxidative stress.
Latest Patents
Dallanoce is named on one patent: Peptide Derivatives and Therapeutic Activity Thereof. The invention describes peptide or pseudopeptide derivatives containing a nitrogenous heterocyclic residue. These compounds are disclosed as having blocking activity against by-products of lipid oxidative stress, particularly unsaturated aldehydes such as malondialdehyde and 4-hydroxy-trans-2-nonenal (HNE). The patent record provided lists 1 patent for Dallanoce.
Career Highlights
Dallanoce’s listed patent reflects research into compounds intended to counter reactive by-products associated with lipid oxidation. Her work is connected with Flamma S.p.a., a company involved in pharmaceutical research and development.
Collaborations
The provided information identifies Stefania Gagliardi and Marco De Amici as Dallanoce’s coworkers. Their names also appear in connection with her professional and patent-related work.
Conclusion
Clelia Dallanoce’s patent work focuses on peptide and pseudopeptide derivatives with potential activity against harmful products of lipid oxidative stress, highlighting her contribution to therapeutic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile